So Hyun Park1,2, Jimi Huh1, Seong Ho Park3, Seung Soo Lee1, Ah Young Kim1, Suk-Kyun Yang4. 1. Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea. 2. Department of Radiology, Gil Medical Center, Gachon University, 21, Namdong-daero 777beon-gil, Namdong-gu, Incheon, South Korea. 3. Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea. parksh.radiology@gmail.com. 4. Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.
Abstract
OBJECTIVES: To prospectively investigate how Buscopan affects the diagnosis of bowel inflammation by diffusion-weighted imaging MR enterography (DWI-MRE) in Crohn's disease (CD). METHODS:Thirty CD patients without previous bowel surgery underwent DWI-MRE (b = 900 sec/mm2) before and after intravenous Buscopan. The 30 patients were randomly divided into two groups; using a crossover design, interpretations were made regarding the presence of restricted mural diffusion (i.e., bowel inflammation) in nine bowel segments in two separate reading sessions by two readers. The readers also judged restricted mural diffusion extent in each bowel segment on two side-by-side DWI-MRE images with a random right-to-left order. Ileocolonoscopy and conventional MRE interpreted by an expert panel were reference standards. RESULTS: We analyzed 262 bowel segments. DWI-MRE without Buscopan significantly decreased sensitivity for both readers (58.8 % vs. 72.9 %, P = 0.046; 57.6 % vs. 85.9 %, P = 0.001) and did not significantly increase specificity (P = 0.085 and 0.396). Two readers noted that 28.6 % and 23.3 % of 262 bowel segments had greater diffusion restriction extent on DWI-MRE with Buscopan compared with DWI-MRE without Buscopan (P < 0.001) and 68.7 % and 74 %, respectively, had similar extent between them. CONCLUSION:Omitting Buscopan caused a greater loss in sensitivity of DWI-MRE than false-positive reduction for diagnosing bowel inflammation in CD. KEY POINTS: • Omitting Buscopan significantly decreases DWI-MRE sensitivity for diagnosing bowel inflammation in CD. • Increase in the corresponding DWI-MRE specificity by omitting Buscopan is less apparent. • DWI-MRE without Buscopan underestimates the extent of bowel inflammation in CD.
RCT Entities:
OBJECTIVES: To prospectively investigate how Buscopan affects the diagnosis of bowel inflammation by diffusion-weighted imaging MR enterography (DWI-MRE) in Crohn's disease (CD). METHODS: Thirty CD patients without previous bowel surgery underwent DWI-MRE (b = 900 sec/mm2) before and after intravenous Buscopan. The 30 patients were randomly divided into two groups; using a crossover design, interpretations were made regarding the presence of restricted mural diffusion (i.e., bowel inflammation) in nine bowel segments in two separate reading sessions by two readers. The readers also judged restricted mural diffusion extent in each bowel segment on two side-by-side DWI-MRE images with a random right-to-left order. Ileocolonoscopy and conventional MRE interpreted by an expert panel were reference standards. RESULTS: We analyzed 262 bowel segments. DWI-MRE without Buscopan significantly decreased sensitivity for both readers (58.8 % vs. 72.9 %, P = 0.046; 57.6 % vs. 85.9 %, P = 0.001) and did not significantly increase specificity (P = 0.085 and 0.396). Two readers noted that 28.6 % and 23.3 % of 262 bowel segments had greater diffusion restriction extent on DWI-MRE with Buscopan compared with DWI-MRE without Buscopan (P < 0.001) and 68.7 % and 74 %, respectively, had similar extent between them. CONCLUSION: Omitting Buscopan caused a greater loss in sensitivity of DWI-MRE than false-positive reduction for diagnosing bowel inflammation in CD. KEY POINTS: • Omitting Buscopan significantly decreases DWI-MRE sensitivity for diagnosing bowel inflammation in CD. • Increase in the corresponding DWI-MRE specificity by omitting Buscopan is less apparent. • DWI-MRE without Buscopan underestimates the extent of bowel inflammation in CD.
Entities:
Keywords:
Butylscopolammonium Bromide; Crohn disease; Diffusion Magnetic Resonance Imaging; Magnetic Resonance Imaging; Parasympatholytics
Authors: J L Cullmann; S Bickelhaupt; J M Froehlich; Z Szucs-Farkas; R Tutuian; N Patuto; H Dawson; M A Patak Journal: Neurogastroenterol Motil Date: 2013-06-07 Impact factor: 3.598
Authors: Onofrio A Catalano; Michael S Gee; Emanuele Nicolai; Francesco Selvaggi; Gianluca Pellino; Alberto Cuocolo; Angelo Luongo; Marco Catalano; Bruce R Rosen; Debra Gervais; Mark G Vangel; Andrea Soricelli; Marco Salvatore Journal: Radiology Date: 2015-10-05 Impact factor: 11.105
Authors: Michael J Steward; Shonit Punwani; Ian Proctor; Yvette Adjei-Gyamfi; Fiona Chatterjee; Stuart Bloom; Marco Novelli; Steve Halligan; Manuel Rodriguez-Justo; Stuart A Taylor Journal: Eur J Radiol Date: 2011-09-15 Impact factor: 3.528
Authors: Jeroen A W Tielbeek; Jesica C Makanyanga; Shandra Bipat; Doug A Pendsé; C Yung Nio; Frans M Vos; Stuart A Taylor; Jaap Stoker Journal: AJR Am J Roentgenol Date: 2013-12 Impact factor: 3.959
Authors: S Bickelhaupt; J M Froehlich; R Cattin; N Patuto; R Tutuian; K U Wentz; J L Culmann; S Raible; H Bouquet; U Bill; M A Patak Journal: Clin Radiol Date: 2013-08-21 Impact factor: 2.350
Authors: T Ullrich; M Quentin; A K Schmaltz; C Arsov; C Rubbert; D Blondin; R Rabenalt; P Albers; G Antoch; L Schimmöller Journal: Eur Radiol Date: 2017-07-07 Impact factor: 5.315